×
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   292.13 (+1.15%)
AAPL   144.79 (+1.31%)
MSFT   266.39 (+0.07%)
META   170.24 (+0.28%)
GOOGL   2,323.01 (+1.38%)
AMZN   114.89 (+0.49%)
TSLA   714.71 (+2.81%)
NVDA   156.26 (+3.28%)
NIO   22.90 (+9.94%)
BABA   123.76 (+3.90%)
AMD   78.41 (+4.06%)
MU   58.58 (+2.11%)
CGC   2.67 (+0.75%)
T   21.09 (+0.33%)
GE   62.92 (+2.19%)
F   11.51 (+4.07%)
DIS   97.01 (+0.97%)
AMC   12.82 (+1.99%)
PFE   53.24 (+0.93%)
PYPL   73.94 (+0.96%)
NFLX   187.16 (+1.68%)
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   292.13 (+1.15%)
AAPL   144.79 (+1.31%)
MSFT   266.39 (+0.07%)
META   170.24 (+0.28%)
GOOGL   2,323.01 (+1.38%)
AMZN   114.89 (+0.49%)
TSLA   714.71 (+2.81%)
NVDA   156.26 (+3.28%)
NIO   22.90 (+9.94%)
BABA   123.76 (+3.90%)
AMD   78.41 (+4.06%)
MU   58.58 (+2.11%)
CGC   2.67 (+0.75%)
T   21.09 (+0.33%)
GE   62.92 (+2.19%)
F   11.51 (+4.07%)
DIS   97.01 (+0.97%)
AMC   12.82 (+1.99%)
PFE   53.24 (+0.93%)
PYPL   73.94 (+0.96%)
NFLX   187.16 (+1.68%)
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   292.13 (+1.15%)
AAPL   144.79 (+1.31%)
MSFT   266.39 (+0.07%)
META   170.24 (+0.28%)
GOOGL   2,323.01 (+1.38%)
AMZN   114.89 (+0.49%)
TSLA   714.71 (+2.81%)
NVDA   156.26 (+3.28%)
NIO   22.90 (+9.94%)
BABA   123.76 (+3.90%)
AMD   78.41 (+4.06%)
MU   58.58 (+2.11%)
CGC   2.67 (+0.75%)
T   21.09 (+0.33%)
GE   62.92 (+2.19%)
F   11.51 (+4.07%)
DIS   97.01 (+0.97%)
AMC   12.82 (+1.99%)
PFE   53.24 (+0.93%)
PYPL   73.94 (+0.96%)
NFLX   187.16 (+1.68%)
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   292.13 (+1.15%)
AAPL   144.79 (+1.31%)
MSFT   266.39 (+0.07%)
META   170.24 (+0.28%)
GOOGL   2,323.01 (+1.38%)
AMZN   114.89 (+0.49%)
TSLA   714.71 (+2.81%)
NVDA   156.26 (+3.28%)
NIO   22.90 (+9.94%)
BABA   123.76 (+3.90%)
AMD   78.41 (+4.06%)
MU   58.58 (+2.11%)
CGC   2.67 (+0.75%)
T   21.09 (+0.33%)
GE   62.92 (+2.19%)
F   11.51 (+4.07%)
DIS   97.01 (+0.97%)
AMC   12.82 (+1.99%)
PFE   53.24 (+0.93%)
PYPL   73.94 (+0.96%)
NFLX   187.16 (+1.68%)
NASDAQ:EXPO

Exponent Stock Forecast, Price & News

$93.23
+1.19 (+1.29%)
(As of 07/7/2022 09:48 AM ET)
Add
Compare
Today's Range
$92.67
$93.23
50-Day Range
$81.00
$103.88
52-Week Range
$80.97
$127.61
Volume
113 shs
Average Volume
226,301 shs
Market Capitalization
$4.83 billion
P/E Ratio
49.59
Dividend Yield
1.06%
Price Target
$120.00

Exponent MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
30.4% Upside
$120.00 Price Target
Short Interest
Bearish
3.07% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
11.54%
From $1.82 to $2.03 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.29 out of 5 stars

Business Services Sector

66th out of 472 stocks

Management Consulting Services Industry

8th out of 27 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive EXPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

Exponent logo

About Exponent (NASDAQ:EXPO) Stock

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

EXPO Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
Research & Consulting Services
Current Symbol
NASDAQ:EXPO
CUSIP
30214U10
Employees
1,215
Year Founded
1967

Company Calendar

Last Earnings
4/28/2022
Ex-Dividend for 6/24 Dividend
6/09/2022
Dividend Payable
6/24/2022
Today
7/07/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$120.00
High Stock Price Forecast
$120.00
Low Stock Price Forecast
$120.00
Forecasted Upside/Downside
+28.7%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
1 Analysts

Profitability

Net Income
$101.20 million
Pretax Margin
26.87%

Debt

Sales & Book Value

Annual Sales
$466.27 million
Cash Flow
$1.93 per share
Book Value
$8.00 per share

Miscellaneous

Free Float
50,786,000
Market Cap
$4.83 billion
Optionable
Optionable
Beta
0.56

Social Links















Exponent Frequently Asked Questions

Should I buy or sell Exponent stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Exponent stock.
View analyst ratings for Exponent
or view top-rated stocks.

What is Exponent's stock price forecast for 2022?

1 analysts have issued 12-month target prices for Exponent's stock. Their EXPO stock forecasts range from $120.00 to $120.00. On average, they predict Exponent's stock price to reach $120.00 in the next year. This suggests a possible upside of 30.4% from the stock's current price.
View analysts' price targets for Exponent
or view top-rated stocks among Wall Street analysts.

How has Exponent's stock performed in 2022?

Exponent's stock was trading at $116.73 at the beginning of 2022. Since then, EXPO stock has decreased by 21.2% and is now trading at $92.04.
View the best growth stocks for 2022 here
.

When is Exponent's next earnings date?

Exponent is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Exponent
.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) released its quarterly earnings data on Thursday, April, 28th. The business services provider reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.04. The business services provider earned $117.90 million during the quarter, compared to analysts' expectations of $115.50 million. Exponent had a net margin of 20.90% and a trailing twelve-month return on equity of 25.02%. The firm's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.58 EPS.
View Exponent's earnings history
.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent announced a quarterly dividend on Thursday, April 28th. Shareholders of record on Friday, June 10th will be paid a dividend of $0.24 per share on Friday, June 24th. This represents a $0.96 annualized dividend and a dividend yield of 1.04%. The ex-dividend date of this dividend is Thursday, June 9th.
View Exponent's dividend history
.

Is Exponent a good dividend stock?

Exponent(NASDAQ:EXPO) pays an annual dividend of $0.96 per share and currently has a dividend yield of 1.06%. Exponent has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Exponent is 51.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Exponent will have a dividend payout ratio of 47.29% next year. This indicates that Exponent will be able to sustain or increase its dividend.
View Exponent's dividend history.

When did Exponent's stock split? How did Exponent's stock split work?

Exponent's stock split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly minted shares were issued to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

Who are Exponent's key executives?

Exponent's management team includes the following people:
  • Dr. Catherine Ford Corrigan P.E., Ph.D., Pres, CEO & Director (Age 53, Pay $1.72M)
  • Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 56, Pay $1.11M) (LinkedIn Profile)
  • Dr. Maureen T. F. Reitman Sc.D., F.S.P.E., P.E., Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director (Age 53, Pay $945.06k) (LinkedIn Profile)
  • Dr. Steven J. Murray P.E., Ph.D., Group VP & Principal Engineer (Age 47, Pay $928.25k) (LinkedIn Profile)
  • Dr. Bernard Ross, Co-Founder, Chairman Emeritus & Principal Engineer
  • Dr. Subbaiah V. Malladi, CTO & Principal Engineer (Age 75)
  • Ms. Sally B. Shepard, Chief HR Officer (Age 61) (LinkedIn Profile)
  • Mr. Eric R. Anderson, VP & Corp. Controller
  • Dr. Robert D. Caligiuri FASM, P.E., Ph.D., Corp. VP of Materials & Corrosion Engineering and Principal Engineer (Age 70)
  • Dr. Paul D. Boehm Ph.D., Corp. VP of Environmental & Health Sciences and Principal Scientist (Age 73)

What is Catherine Corrigan's approval rating as Exponent's CEO?

15 employees have rated Exponent CEO Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among Exponent's employees.

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $92.04.

How much money does Exponent make?

Exponent (NASDAQ:EXPO) has a market capitalization of $4.77 billion and generates $466.27 million in revenue each year. The business services provider earns $101.20 million in net income (profit) each year or $1.88 on an earnings per share basis.

How many employees does Exponent have?

Exponent employs 1,215 workers across the globe.

Does Exponent have any subsidiaries?

The following companies are subsidiares of Exponent: Dennis Publishing.
Read More

When was Exponent founded?

Exponent was founded in 1967.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The official website for Exponent is www.exponent.com. The business services provider can be reached via phone at (650) 326-9400, via email at investor-relations@exponent.com, or via fax at 650-326-8072.

This page (NASDAQ:EXPO) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.